To investigate the difference of the difference between the nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the fatal Patients .The cross sectional study was undertaken to compare the clinical information (laboratory and radiologic characteristics)of nonfatal participants and fatal cases. The investigators wish figure out the clinical character of the fatal participants. The result may help the physician to find the fatal patients with COVID-19 more easily. The fatal patients with COVID-19 could be treated early.
Study Type
OBSERVATIONAL
Enrollment
100
no intervention
The First Affiliated Hospital of Guangzhou Medical University
Guanzhou, Guangdong, China
Hankou Hospital
Wuhan, Hubei, China
Lymphocyte cell
the counting of Lymphocyte(counts/L)
Time frame: 2 month
d-dimer
d-dimer（mg/L）
Time frame: 2 month
PLT
the counting of Platelets（(counts/L)）
Time frame: 2 month
CRP
the level of C-reactive protein (mg/uL)
Time frame: 2 month
LDH
lactate dehydrogenase ( U/L)
Time frame: 2 month
CK
creatine kinase (U/L)
Time frame: 2 month
PT
prothrombin time(second)
Time frame: 2 month
ALT
alanine aminotransferase(U/L)
Time frame: 2 month
AST
aspartate aminotransferase(U/L)
Time frame: 2 month
NK cell
natural killer cell(counts/L)
Time frame: 2 month
PCT
procalcitonin（ng/ml）
Time frame: 2 month
IL-6
interleukin-6(mg/L)
Time frame: 2 month
the clinical difference of radiologic characteristics between the fatal patients with COVID -19 and the non fatal cases
CT scan feature
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.